Orally Administered Semaglutide Versus GLP-1 RAs in Patients with Type 2 Diabetes Previously Receiving 1–2 Oral Antidiabetics: Systematic Review and Network Meta-Analysis

INTRODUCTION: Orally administered semaglutide is the first glucagon-like peptide 1 receptor agonist (GLP-1 RA) for oral administration. As head-to-head trials assessing orally administered semaglutide as an add-on to 1–2 oral antidiabetic drugs (OADs) vs other GLP-1 RAs are limited, a network meta-a...

Descripción completa

Detalles Bibliográficos
Autores principales: Nuhoho, Solomon, Gupta, Jatin, Hansen, Brian Bekker, Fletcher-Louis, Mary, Dang-Tan, Tam, Paine, Abby
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848399/
https://www.ncbi.nlm.nih.gov/pubmed/31599391
http://dx.doi.org/10.1007/s13300-019-00706-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848399/
https://www.ncbi.nlm.nih.gov/pubmed/31599391
http://dx.doi.org/10.1007/s13300-019-00706-y

Ejemplares similares